Just Published: "Epilepsy Drugs Market in Europe - Market Analysis 2015-2019"

Epilepsy refers to a spectrum of brain disorders manifested by benign to severe, disabling, and life-threatening symptoms. It is caused by factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and trauma during birth. When the underlying cause of the disease is unidentified, as is witnessed in the majority of cases, it is known as idiopathic epilepsy. An imbalance between the inhibitory and excitatory signals of the brain, leading to a sudden onset of excitation, results in seizures.

Full Report Details at
- http://www.fastmr.com/prod/1055976_epilepsy_drugs_europe.aspx?afid=301

Technavio's analysts forecast the epilepsy drugs market in Europe to grow at a CAGR of 3.22% over the period 2014-2019.

Covered in this report
The report includes the present scenario and the growth prospects of the epilepsy drugs market in Europe for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of epilepsy.

Technavio's report, Epilepsy Drugs Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as market segmentation and pipeline landscape. The report includes a discussion of the key vendors operating in this market.

Key vendors

* Eisai
* GlaxoSmithKline
* Pfizer
* UCB

Other prominent vendors

* AbbVie
* Janssen Pharmaceuticals
* Lundbeck
* Meda
* Novartis
* Roche
* Shire
* Sunovion Pharmaceuticals
* Supernus Pharmaceuticals
* Upsher-Smith
* Valeant Pharmaceuticals

Market driver

* Unmet medical needs
* For a full, detailed list, view our report

Market challenge

* Patent expiry
* For a full, detailed list, view our report

Market trend

* Reformulation of marketed drugs
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2019 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?
* What are the strengths and weaknesses of the key vendors?

Companies Mentioned in this Report: Eisai, UCB Pharma, Pfizer, GlaxoSmithKline, AbbVie, Roche, Lundbeck, Janssen Pharmaceuticals, Meda, Novartis, Shire, Sunovion Pharmaceuticals, Supernus Pharmaceuticals, Upsher-Smith, Valeant Pharmaceuticals.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Global Neurodegenerative Diseases Market 2015-2019
- Global Colorectal Cancer Drugs Market 2015-2019
- Epilepsy Therapeutics Market in the APAC Region 2015-2019
- PharmaPoint: Macular Edema and Macular Degeneration - Global Drug Forecast and Market Analysis to 2023
- PharmaPoint: Insomnia - Global Drug Forecast and Market Analysis to 2023